InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,650.29
(
0.62%
)
US TECH 100
19,946.80
(
0.78%
)
Dow Jones
40,307.60
(
0.77%
)
Brent Oil
84.37
(
-0.27%
)
Bitcoin
62,952.67
(
3.57%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: opportunityknocking post# 16435

Thursday, 10/02/2008 2:19:41 PM

Thursday, October 02, 2008 2:19:41 PM

Post# of 30387
Opportunity, I remember when those patents were posted. Abbott listed every antibody and biomarker they had access to in those patents.

For Abbott to be doing any work with RECAF WHAT SO EVER, they would have to give notice to BioCurex and resume paying minimum royalties, milestones, etc. The amended agreement is only a few months old and much more current than anything stated in previous patents in regard to markers Abbott had at the time of application.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up